Literature DB >> 26303488

Mild Chronic Intermittent Hypoxia in Wistar Rats Evokes Significant Cardiovascular Pathophysiology but No Overt Changes in Carotid Body-Mediated Respiratory Responses.

Clare J Ray1, Ben Dow, Prem Kumar, Andrew M Coney.   

Abstract

Models of chronic intermittent hypoxia (CIH), the main feature of obstructive sleep apnoea (OSA), have demonstrated dysregulation of the cardiovascular and respiratory systems resulting in hypertension, cardiac hypertrophy and alterations in the hypoxic ventilatory response (HVR) due to changes in sympathetic and respiratory control by the carotid body. In the UK, treatment of OSA is only offered to patients with an apnoea-hypopnoea index (AHI) >15, we investigated whether mild CIH produced significant pathophysiological changes, which might inform treatment guidelines.Rats were exposed to CIH (6 h(-1), 8 h day(-1), 5 % O(2) nadir) for 2 weeks and then arterial blood pressure (ABP), heart rate (HR) and ventilation were recorded in these and normoxic control rats (N) under Alfaxan anaesthesia, at baseline and in response to Dejours test, graded hypoxia and hypercapnia. Hearts were analysed post-mortem.CIH induced significant increases in baseline ABP (142 ± 5 vs 122 ± 2 mmHg), HR (448 ± 9 vs 412 ± 5 bpm) and cardiac mass (3.5 ± 0.1 vs 2.7 ± 0.1 g kg body mass(-1)) as a result of a selective left ventricular hypertrophy (1.6 ± 0.1 vs 1.3 ± 0.08 g kg body mass(-1); FCSA 464 ± 32 μm(2) vs 314 ± 9 μm(2)). There was no significant difference between N and CIH in baseline respiration or the response to Dejours test, graded hypoxia and hypercapnia.These results demonstrate that mild CIH can induce the significant cardiovascular changes associated with OSA without overt changes in respiratory function. Given evidence that CIH changes carotid body sensory activity, a possible explanation for these results is that there is differential integration of chemoreceptor input with respiratory and cardiac sympathetic outputs.

Entities:  

Mesh:

Year:  2015        PMID: 26303488     DOI: 10.1007/978-3-319-18440-1_28

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  6 in total

1.  Chronic intermittent hypoxia alters ventilatory and metabolic responses to acute hypoxia in rats.

Authors:  Barbara J Morgan; Russell Adrian; Zun-Yi Wang; Melissa L Bates; John M Dopp
Journal:  J Appl Physiol (1985)       Date:  2016-02-25

2.  Role of raphe magnus 5-HT1A receptor in increased ventilatory responses induced by intermittent hypoxia in rats.

Authors:  Jiao Su; Yang Meng; Yifei Fang; Linge Sun; Mengge Wang; Yanjun Liu; Chunling Zhao; Liping Dai; Songyun Ouyang
Journal:  Respir Res       Date:  2022-03-03

3.  Chronic intermittent hypoxia disrupts cardiorespiratory homeostasis and gut microbiota composition in adult male guinea-pigs.

Authors:  Eric F Lucking; Karen M O'Connor; Conall R Strain; Fiona Fouhy; Thomaz F S Bastiaanssen; David P Burns; Anna V Golubeva; Catherine Stanton; Gerard Clarke; John F Cryan; Ken D O'Halloran
Journal:  EBioMedicine       Date:  2018-11-13       Impact factor: 8.143

4.  Metoprolol Inhibits Profibrotic Remodeling of Epicardial Adipose Tissue in a Canine Model of Chronic Obstructive Sleep Apnea.

Authors:  Hui Dai; Yue Yuan; Shuangli Yin; Yun Zhang; Yu Han; Li Sun; Tiankai Li; Jicheng Xu; Li Sheng; Yongtai Gong; Yue Li
Journal:  J Am Heart Assoc       Date:  2019-02-05       Impact factor: 5.501

5.  β-Adrenoceptor blockade prevents carotid body hyperactivity and elevated vascular sympathetic nerve density induced by chronic intermittent hypoxia.

Authors:  Abdulaziz A Alzahrani; Lily L Cao; Hayyaf S Aldossary; Demitris Nathanael; Jiarong Fu; Clare J Ray; Keith L Brain; Prem Kumar; Andrew M Coney; Andrew P Holmes
Journal:  Pflugers Arch       Date:  2020-11-19       Impact factor: 3.657

6.  Prebiotic administration modulates gut microbiota and faecal short-chain fatty acid concentrations but does not prevent chronic intermittent hypoxia-induced apnoea and hypertension in adult rats.

Authors:  Karen M O'Connor; Eric F Lucking; Thomaz F S Bastiaanssen; Veronica L Peterson; Fiona Crispie; Paul D Cotter; Gerard Clarke; John F Cryan; Ken D O'Halloran
Journal:  EBioMedicine       Date:  2020-08-30       Impact factor: 8.143

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.